ALBO
Albireo Pharma, Inc. Common Stock
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
69 hedge funds and large institutions have $270M invested in Albireo Pharma, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 8 closing their positions.
Holders
69
Holders Change
+19
Holders Change %
+38%
% of All Funds
1.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
21
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$18.6M |
| 2 |
2
Federated Hermes
Pittsburgh,
Pennsylvania
|
$20.8M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$4.98M |
| 4 |
ACH
4
ArrowMark Colorado Holdings
Denver,
Colorado
|
$18.2M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$3.54M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LCM
76
Laurion Capital Management
New York
| – | – | -6,438 | Closed |
|
77
Group One Trading
Chicago,
Illinois
| $0 | 2 | – | – |
|